About Corifollitropin alfa
            
            Class: | Gonadotropin, Follicle Stimulating Hormone (FSH) analog  
Use: | Induction of ovulation in women undergoing assisted reproductive technology (ART) and for the stimulation of follicular development in women with hypogonadotropic hypogonadism  
Adult dose: | 150 mcg administered as a subcutaneous injection once weekly for up to 5 weeks, followed by monitoring and possible adjustment based on ovarian response  
Pediatric dose: | Not applicable; not indicated for pediatric use  
Side effect
         
        
            
                
                
                    
                        Drug Class
                    
                    Gonadotropin, Follicle Stimulating Hormone (FSH) analog
                 
                
                
                    
                        Uses & Indications
                    
                    Induction of ovulation in women undergoing assisted reproductive technology (ART) and for the stimulation of follicular development in women with hypogonadotropic hypogonadism
                 
                
                
                    
                        Storage Requirements
                    
                    Store in a refrigerator (2°C to 8°C); do not freeze. Protect from light. Once removed from the refrigerator, it can be stored at room temperature (up to 25°C) for a maximum of 3 days
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: N.V. Organon, NETHERLANDS
                    
                    
                    Package Size
                    0.5ml Pre-filled Syringe
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 1792.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        150 mcg administered as a subcutaneous injection once weekly for up to 5 weeks, followed by monitoring and possible adjustment based on ovarian response
                    
                    
                        Pediatric Dose
                    
                    
                        Not applicable; not indicated for pediatric use
                    
                 
                
                
                    
                        Side Effects
                    
                    Ovarian hyperstimulation syndrome (OHSS), headache, abdominal pain, nausea, injection site reactions, breast tenderness
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to corifollitropin alfa or any component of the formulation, uncontrolled thyroid or adrenal dysfunction, ovarian cysts or enlargement, pregnancy, and known or suspected sex hormone-dependent tumors
         
        
        
            
                Important Warnings
            
            Risk of OHSS, which can be serious; monitor for signs of OHSS. Use with caution in patients with a history of thromboembolic disease. Regular monitoring of ovarian response is essential during treatment.
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.